Search results for "Carcinoma 256"

showing 1 items of 1 documents

HPMA-LMA copolymer drug carriers in oncology: an in vivo PET study to assess the tumor line-specific polymer uptake and body distribution.

2013

Polymeric drug carriers aim to selectively target tumors in combination with protecting normal tissue. In this regard polymer structure and molecular weight are key factors considering organ distribution and tumor accumulation of the polymeric drug delivery system. Four different HPMA based copolymer structures (random as well as block copolymers with lauryl methacrylate as hydrophobic block) varying in molecular weight, size and resulting architecture were analyzed in two different tumor models (AT1 prostate carcinoma and Walker-256 mammary carcinoma) in vivo. Polymers were labeled with (18)F and organ/tumor uptake was followed by μPET imaging and ex vivo biodistribution. Vascular permeabi…

MaleBiodistributionPolymers and PlasticsBioengineeringVascular permeabilityBiomaterialschemistry.chemical_compoundPolymethacrylic AcidsIn vivoPolymer chemistryMaterials ChemistryDistribution (pharmacology)AnimalsTissue DistributionWhole Body ImagingCarcinoma 256 WalkerParticle SizeChemistryProstatic NeoplasmsIn vitroRatsDextranPositron-Emission TomographyBiophysicsMethacrylatesNanoparticlesRadiopharmaceuticalsDrug carrierEx vivoNeoplasm TransplantationBiomacromolecules
researchProduct